Reuters: Mergers News: UPDATE 1-Warner Chilcott to explore alternatives

Reuters: Mergers News Reuters.com is your source for breaking news, business, financial and investing news, including personal finance and stocks. Reuters is the leading global provider of news, financial information and technology solutions to the world's media, financial institutions, businesses and individuals. // via fulltextrssfeed.com

UPDATE 1-Warner Chilcott to explore alternatives Apr 30th 2012, 14:36 Mon Apr 30, 2012 10:36am EDT April 30 (Reuters) - Specialty pharmaceutical company Warner Chilcott PLC said it would explore strategic options, including preliminary talks with potential offerors, sending its shares up 24 percent. The company, which makes women's healthcare and dermatology products, said it hired Goldman Sachs as its financial adviser. The announcement comes after reports of Bayer AG making a bid for the Irish drugmaker at $32 per share. Last week, sources told Reuters that the German drugs and plastics maker Bayer was close to making a multi-billion euro acquisition to strengthen its healthcare division. In January, Warner Chilcott had forecast a weak 2012 on lower sales and loss of market exclusivity for its key osteoporosis drug Actonel in Western Europe. Warner Chilcott's acne drug Doryx also faces generic threat. Warner Chilcott shares, which have risen 24 percent in value so far this year, jumped as much as 24 percent to $23.28 on Monday on Nasdaq.

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions